Pharmafile Logo

Realizing the Potential of Virtual Patient Simulation With Real-World Outcomes

September 18, 2024 |  

We’re celebrating Healthcare Simulation Week 2024 by highlighting the transformative power of our multi-award-winning medical simulation programs, which have proven impact in delivering significant improvements in clinical skills and outcomes.

In this latest article we dive into the growth of virtual patient simulations and share insights from our Chief Impact Officer, Katie S Lucero. Discover how integrating real-world outcomes tools is enhancing healthcare providers’ experiences and driving better patient care.

- PMLiVE

Simulation is a vital component of medical education and is increasingly being used in postgraduate settings for practicing clinicians who are training and certifying learners to assess their knowledge, skills, and confidence in real-life healthcare settings and ultimately, improve patient outcomes.

Spurred on by the COVID-19 pandemic, an increased focus on patient safety, the growing demand for minimally invasive treatments, and advancements in technology, the demand for virtual patient simulation continues to grow. By 2028, the virtual simulation market is expected to reach 8.97 billion.

- PMLiVE

Although virtual simulation programs can provide education evaluators with valuable data about learners’ actions, including areas where they made improvements and where learning gaps remain, real-world outcomes are a critical aspect that should be integrated into any program.

“We know that programs measure impact using real-world outcomes are one of the few ways to understand whether knowledge, skills, and/or self-efficacy learners have acquired is being applied in the real world, ultimately leading to better patient outcomes,” according to Katie Lucero, PhD, Chief Impact Officer, Medscape Education.

The Importance of Real-World Outcomes

Virtual patient simulation has a number of use cases and allows practicing healthcare professionals an opportunity to interview and examine patients, order tests and exams, deliver interventions, and observe the patient’s response to therapy in real time.

Research also shows that virtual patient simulation can improve clinical decision-making. In fact, according to a 2022 systematic review and meta-analysis, nursing students and nurses who utilized virtual simulation demonstrated a significant improvement in clinical reasoning based on applied knowledge and clinical performance compared to learners in the control group.

Outcome measurements derived from virtual simulation programs can provide rich quantitative and qualitative data, including correct and incorrect responses, pre- and post-intervention assessments, and learner evaluations tied to specific educational objectives.

Although these data allow supervising physicians to quickly and easily understand the impact of the program by comparing learners’ baseline knowledge to improvements after interventions are delivered, they only capture short-term outcomes. “To determine the long-term efficacy of the program, education evaluators must examine how learners applied their newfound knowledge in clinical practice,” Lucero said.

Affecting Behavior Change With Medscape Real-World Outcomes

Real-World Outcomes, an advanced Medscape assessment approach, works by analyzing learners’ behaviors in the real world before and after they participate in the education activity. The tool can determine if the knowledge they acquired has been applied in the real world to ensure a positive impact on patients over a longer period of time.

Our research shows while learners may answer questions correctly after completing a module, for example, fewer learners are exhibiting behavior change in the real world. “While this doesn’t mean that the education was ineffective, it may reveal insights into what worked for whom and and why to inform education strategy over time,” Lucero said. Our MedSims virtual patient simulation solution and Real-World Outcomes tool have been shown to positively affect behavior change. In fact, a 2023 studyin the journal JMIR Medical Education, which aimed to evaluate the effect of the MedSims VPS platform on the real-world selection of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type-2 diabetes, found the CME resulted in a 29 percentage point increase in correct decisions from pre to post feedback. The study also found that the learners were 4 times more likely to select guideline-based treatment for patients after CME than the control group.

What’s more, a 2020 instructional design studyby the Calibre Institute for Quality Medical Education found 5 activities representing various therapeutic areas in the MedSims solution have a high potential to engage physicians and lead to improvements in practice.

At Medscape Education, we not only deliver impact, we guarantee it. Our virtual patient simulation programs have been proven in multiple studies to improve care and drive better decision-making. With the backing of Real-World Outcomes methods, we know MedSims has the power to change patient care.

“When clinicians participate in simulation programs, we see a significant improvement in skills, confidence, and behavior change,” according to Lucero. “With Real-World Outcomes, we have a powerful set of data that we’re leveraging to evolve our programs and advance our outcomes research which will only improve the education we can provide clinicians.”

For more information on MedSims and Real-World Outcomes, contact your local Medscape representative or one of our team leads:

For the US please contact: Piyali Chatterjee-Shin , Jess Dropkin, David Anderson or Chris Carey

For OUS please contact: Peter Schoonheim or Jelena Spyropoulos

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Dermatology in Focus: Medscape Sponsors SDNP’s 2025 National Conference

Medscape Education is a proud sponsor of the 2025 SDNP National Conference, taking place from April 30 to May 3 at the Renaissance Esmeralda Resort and Spa in Indian Wells,...

Medscape Education: Proud Friend of COA Sponsor at the Community Oncology Conference

Medscape Education is honored to be a Friend of COA sponsor at the Community Oncology Conference, taking place from April 28-30th in Orlando, FL. This partnership highlights our commitment to...

A Commitment to Elevating Patient Engagement and Integration

Medscape is honored to be the lead sponsor of the upcoming Measuring Patient Engagement Summit, taking place in Boston from April 29 to May 1. This event marks a pivotal...

Medscape Education Global to Join Biotechs at Swiss Biotech Day

The Medscape Education Global team is excited to announce its participation in Swiss Biotech Day, taking place in Basel from May 5-6. This marks our inaugural attendance at this event,...

Gut Check: A Game-Changing Experience at DDW 2025 with Medscape!

The countdown is on! The Medscape team is heading to San Diego for this year’s highly anticipated Digestive Disease Week (DDW) conference—and you won’t want to miss what we’ve got...

Looking Ahead: Transparency, Impact, and Instructional Design at CMEpalooza Spring 2025

Tomorrow at 2 PM ET, join Medscape for a thought-provoking Afternoon Snack Session at CMEpalooza Spring 2025, titled “Reverse Planning with Forward Thinking.” This session will spotlight how clear communication...

Vaccines Are the Most Impactful Innovation in Health Equity

As deadly as the measles outbreak in west Texas and New Mexico is the spread of vaccine conspiracy theories and misinformation. According to KFF research from November 2024, childhood vaccination...

Collaboration Across Healthcare is the Path Forward

How do we impress upon women that they need to prioritize their own health before providing for the people who need them? A leader in medical oncology has a few...

Medscape at ESCMID 2025: Advancing Infectious Disease Education

Medscape, a global leader in infectious disease education, continues its commitment to advancing knowledge in the field. With 1.47 million ID learners in 2024, the Medscape team will travel to...

The future of heart health with AI-powered devices and treatment approaches

Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and...